Figure 4

Comparison of physician adherence in this study with previous heart failure registry studies. ARNI, angiotensin receptor-neprilysin inhibitor; BB, beta-blocker; MRA, mineralocorticoid receptor antagonist; RASi, renin–angiotensin–aldosterone system inhibitor.